Housing transactions last month totaled 17,591 units in the six special municipalities, down 29.7 percent from one month earlier, as the market started to feel the chilling effect of a local COVID-19 outbreak.
The number represented a 25 percent decline from the same month last year, data from land administration agencies in Taipei, New Taipei City, Taoyuan, Taichung, Tainan and Kaohsiung showed.
Sinyi Realty Inc (信義房屋) said the latest data reflect deals that mainly took place in June, as it takes about one month to registers a transaction.
Photo: Hsieh Wu-hsiung, Taipei Times
The market started to improve last month, when the daily number of local COVID-19 infections dropped to between 20 and 30, and the government allowed the conditional reopening of entertainment and recreational facilities last week, Sinyi researcher Tseng Ching-der (曾進德) said yesterday, adding that the government data are a lagging indicator.
Taichung reported the steepest month-on-month decline of 44.1 percent to 2,657 deals, followed by Taipei’s 34.7 percent fall to 1,937 transactions, local government figures showed.
Transactions in Taoyuan and Kaohsiung both shrank 29 percent to 3,011 and 2,981 deals respectively.
The number of transactions in Tainan slid 22 percent to 2,545 units, while New Taipei City posted a 20.5 percent decline to 4,460 deals, data showed.
Tseng said the worst is likely over, judging by house-hunting interest, although uncertainty lingers.
Health authorities yesterday said they would extend the level 2 alert next week, but modestly loosen gathering restrictions for certain venues.
In the first seven months of this year, total transactions in the six cities totaled 152,000 units, up 15.6 percent from a year earlier, data showed.
Cash-strapped developer China Evergrande Group (恆大集團) has begun repaying investors in its wealth management products with real estate, said Hengda Real Estate Group Co Ltd (恆大地產), its main unit. Evergrande, with more than US$300 billion in liabilities, is in the throes of a liquidity crisis that has left it racing to raise funds to pay its many lenders and suppliers. It has a bond interest payment of US$83.5 million due on Thursday. The company said on WeChat on Saturday that investors interested in redeeming wealth management products for physical assets should contact their investment consultants or visit local offices. Financial news outlet Caixin on
WORK SUSPENDED: A Taiwanese maker of golf club heads said that it expects the situation to normalize next quarter, thanks to rising vaccination rates in Vietnam Several Taiwanese manufacturers in Vietnam have been struggling with production problems over the past few weeks, as the country’s south remains under a COVID-19 lockdown. Pou Chen Corp (寶成工業), an original design manufacturer for international footwear brands, said that production at its factory in Ho Chi Minh City has ground to a halt, so it expects a significant drop in revenue at that factory from July to last month. If the COVID-19 outbreak in southern Vietnam subsides in the fourth quarter of this year and employees are allowed to return to work, they might be able to put in some overtime,
‘CORE VALUES’: The contract chipmaker did not specify why the employees were dismissed, but media reports said they had leaked information about customer orders Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has fired seven of its employees for violating the company’s “core values,” the world’s largest contract chipmaker said yesterday. While the company did not disclose exactly why it fired the seven employees, local media reports earlier in the day said that the employees had leaked confidential information about customer orders. In a statement, the company said that it fired the seven at once, adding that it released an internal notice last week to inform the entire company of the move ahead of the four-day Mid-Autumn Festival holilday, which ended on Tuesday. TSMC said it fired the seven
Medigen Vaccine Biologics Corp’s (高端疫苗) board of directors yesterday approved a proposal to conduct a phase 3 clinical trial of its COVID-19 vaccine in Europe, it said yesterday. The final stage of human tests, if approved by the European Medicines Agency (EMA), would mark a big milestone in the COVID-19 vaccine development of Medigen, which has so far completed phase 1 and 2 clinical trials in Taiwan and is conducting a small phase 3 clinical trial in Paraguay. Medigen in July consulted the EMA about conducting clinicial trials of its vaccine and it received a “positive response” from the agency, the company